Skip to content

The Efficacy of Selective Laser Trabeculoplasty

Clinical Results of Selective Laser Trabeculoplasty in Treatment of Open Angle Glaucoma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00347893
Enrollment
Unknown
Registered
2006-07-04
Start date
2006-05-31
Completion date
Unknown
Last updated
2006-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ocular Hypertension, Pigment Dispersion Glaucoma, Primary Open Angle Glaucoma, Pseudo-Exfoliative Glaucoma

Keywords

Primary open angle glaucoma, Ocular hypertension, Pseudo-exfoliative glaucoma, Pigment Dispersion glaucoma, selective laser trabeculoplasty, intraocular pressure

Brief summary

Selective laser trabeculoplasty (SLT) is a new method to reduce intraocular pressure in eyes with open angle glaucoma or ocular hypertension. SLT may also be effective for cases with previously failed ALT procedures. We will study the efficacy and safety of the SLT procedure.

Detailed description

Selective laser trabeculoplasty (SLT) has been shown to be a safe, well tolerated, and effective intraocular pressure reduction therapy for several forms of open-angle glaucoma. SLT produces significantly less disturbance to the trabecular meshwork and is theoretically more repeatable than the ALT procedure. This retrospective research will begin with cases treated in 2001. It will evaluate whether SLT is effective for patients who have had prior treatment with ALT and it will determine whether the IOP lowering effect is sustainable over time. It will also assess the efficacy of repeated SLT procedures.

Interventions

PROCEDURESelective laser trabeculoplasty

Sponsors

PharmaLogic Development, Inc.
CollaboratorINDUSTRY
Glaucoma Research & Education Group
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients with primary open angle glaucoma, ocular hypertension, pseudo exfoliative glaucoma, pigment dispersion glaucoma

Exclusion criteria

* History of prior invasive glaucoma surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026